Targeting ATR enhances the antitumor efficacy of patritumab deruxtecan (HER3-DXd)in tamoxifen-resistant ER+ breast cancer cells by inducing DNA damage and apoptosis-MedSci.cn

Targeting ATR enhances the antitumor efficacy of patritumab deruxtecan (HER3-DXd)in tamoxifen-resistant ER+ breast cancer cells by inducing DNA damage and apoptosis

Xie, XM; Lee, JS; Fuson, JA; Liu, H; Gi, YJ; Poullikkas, T; Fan, PD; Koyama, K; Tripathy, D; Ueno, NT

CANCER RESEARCH, 2023; 83 (8):

科室
- - 订阅+
  - 更多科室
工具
服务